mTOR inhibition as an adjuvant therapy in a metastatic model of HPV+ HNSCC

Effective treatments for recurrent/metastatic human papillomavirus-positive (HPV+) head and neck squamous cell cancer (HNSCC) are limited. To aid treatment development, we characterized a novel murine model of recurrent/metastatic HPV+ HNSCC. Further analysis of the parental tumor cell line and its...

Descripción completa

Detalles Bibliográficos
Autores principales: Coppock, Joseph D., Vermeer, Paola D., Vermeer, Daniel W., Lee, Kimberly M., Miskimins, W. Keith, Spanos, William C., Lee, John H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5029697/
https://www.ncbi.nlm.nih.gov/pubmed/27015118
http://dx.doi.org/10.18632/oncotarget.8286

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5029697/
https://www.ncbi.nlm.nih.gov/pubmed/27015118
http://dx.doi.org/10.18632/oncotarget.8286

Ejemplares similares